Driving simulator performance and psychomotor functions of schizophrenic patients treated with antipsychotics

European Archives of Psychiatry and Clinical Neuroscience

Volumn 259, Issue 8, 2009, Pages 483-489

  Brunnauer, Alexander ^a   Laux, Gerd ^a,b   Zwick, Sarah ^a  

^a Inn Salzach Klinikum   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Antipsychotics; Driving ability; Schizophrenia; Simulated driving performance

Indexed keywords

AMISULPRIDE; FLUPENTIXOL; HALOPERIDOL; QUETIAPINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRIVING ABILITY; FEMALE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA; SCORING SYSTEM; SIMULATOR; TASK PERFORMANCE;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; ATTENTION; AUTOMOBILE DRIVER EXAMINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC; VISUAL PERCEPTION; YOUNG ADULT;

EID: 73449107127     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-009-0014-4     Document Type: Article

References (34)

1. BW Palmer RK Heaton JA Gladsjo JD Evans TL Patterson S Golshan DV Jeste 2002 Heterogeneity in functional status among older outpatients with schizophrenia: employment history, living situation, and driving Schizophr Res 55 205 215 10.1016/S0920-9964(01)00218-3 12048144 (Pubitemid 34607375)
2. Brunnauer A, Laux G, Zwick S, David I, Schmauss M, Messer Th, Möller H-J, Hermisson I, Steinberg R, Frommberger (2008) Mobility behaviour of patients with mental illness. Dtsch Z Nervenheilkd 27(suppl):120-121
3. M Hambrecht M Lammertink J Klosterkötter E Matuschek R Pukrop 2002 Subjective and objective neuropsychological abnormalities in a psychosis prodrome clinic Br J Psychiatry 43 30 37 10.1192/bjp.181.43.s30
4. DI Velligan AL Miller 1999 Cognitive dysfunction in schizophrenia and its importance to outcome: the place of atypical antipsychotics in treatment J Clin Psychiatry 60 Suppl 23 25 28 10625197
5. MF Green RS Kern RK Heaton 2004 Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS Schizophr Res 72 41 51 10.1016/j.schres.2004.09.009 15531406 (Pubitemid 39452904)
6. DI Velligan DJ Prihoda D Sui JL Ritch N Maples AL Miller 2003 The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings J Clin Psychiatry 64 524 531 1:CAS:528:DC%2BD3sXkslOis74%3D 12755654
7. MJ Edlund C Conrad P Morris 1989 Accidents among schizophrenic outpatients Compr Psychiatry 30 522 526 10.1016/0010-440X(89)90082-5 1:STN:280:DyaK3c%2FlvFajug%3D%3D 2582756 (Pubitemid 19279364)
8. JA Waller 1965 Chronic medical conditions and traffic safety: a review of the California experience N Engl J Med 273 1413 1420 1:STN:280: DyaF28%2FltVSruw%3D%3D 5848415
9. RC Elkem J Bronssean R Koshnick C McGee 1970 A statistical study on the relationship between mental illness and traffic accidents-a pilot study Am J Public Health 60 459 469 10.2105/AJPH.60.3.459
10. HJ Grabe T Wolf S Gratz G Laux 1999 The influence of clozapine and typical neuroleptics on information processing of the central nervous system under clinical conditions in schizophrenic disorders: implications for fitness to drive Neuropsychobiology 40 196 201 10.1159/000026619 1:CAS:528: DyaK1MXotVCitLY%3D 10559702 (Pubitemid 29515733)
11. A Brunnauer G Laux E Geiger H-J Moeller 2004 The impact of antipsychotics on psychomotor performance with regards to car driving skills J Clin Psychopharmacol 24 155 160 10.1097/01.jcp.0000116648.91923.82 1:CAS:528:DC%2BD2cXjslSit74%3D 15206662 (Pubitemid 38380839)
12. S Kagerer C Winter HJ Moeller M Soyka 2003 Effects of haloperidol and atypical neuroleptics on psychomotor performance and driving ability in schizophrenic patients. Results from an experimental study Neuropsychobiology 47 212 218 10.1159/000071217 1:CAS:528:DC%2BD3sXkvVegs7c%3D 12824745 (Pubitemid 36735235)
13. KR Wylie DJ Thompson HJ Wildgust 1993 Effects of depot neuroleptics on driving performance in chronic schizophrenic patients J Neurol Neurosurg Psychiatry 56 910 913 10.1136/jnnp.56.8.910 1:STN:280:DyaK3szltlajtA%3D%3D 8102393
14. M Soyka C Winter S Kagerer A Brunnauer G Laux H-J Moeller 2005 Effects of haloperidol and risperidon on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls J Psychiatr Res 39 1 101 108 10.1016/j.jpsychires.2004.04.006 15504428 (Pubitemid 39422290)
15. M Soyka S Kagerer A Brunnauer 2005 Driving ability in schizophrenic patients: effects of neuroleptics Int J Psychiatr Clin Pract 9 3 168 174 10.1080/13651500510029237 1:CAS:528:DC%2BD2MXhtVWitbbK (Pubitemid 41499384)
16. K Tanida E Poeppel 2006 A hierarchical model of operational anticipation windows in driving an automobile Cogn Process 7 275 287 10.1007/s10339-006-0152- 9 16988812 (Pubitemid 44730423)
17. MJ Rapoport MC Banina 2007 Impact of psychotropic medications on simulated driving: a critical review CNS Drugs 21 6 503 519 10.2165/00023210- 200721060-00006 1:CAS:528:DC%2BD2sXot1Sns78%3D 17521229 (Pubitemid 46849185)
18. B Bukasa R Kisser U Wenninger 1990 Computergestützte Leistungsdiagnostik bei verkehrspsychologischen Eignungsuntersuchungen Diagnostica 36 148 165
19. T Karner B Biehl 2001 Über die Zusammenhänge verschiedener Versionen von Leistungstests im Rahmen der verkehrspsychologischen Diagnostik Z Verkehrssicherheit 42 53 63
20. A Brunnauer E Geiger G Laux Th Glaser M Soyka H-J Moeller 2005 Fahrsimulation und psychomotorische Leistungsfähigkeit schizophrener Patienten Psychopharmakotherapie 12 3 91 96
21. A Brunnauer G Laux E Geiger M Soyka H-J Moeller 2006 Antidepressants and driving ability: results from a clinical study J Clin Psychiatry 67 1776 1781 1:CAS:528:DC%2BD28XhtlGhs7nM 17196059
22. S Dittert M Soyka C Winter H-J Moeller 1999 Cognition and driving in schizophrenic patients under treatment with risperidone vs. haloperidol Fortschr Neurol Psychiatr Suppl 2 S70 S73 10.1055/s-2007-995304
23. B Gallhofer U Bauer S Lis S Krieger H Gruppe 1996 Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs Eur Neuropsychopharmacol 6 Suppl 2 S13 S20 10.1016/0924-977X(96)00010-7 8792116
24. PD Harvey RS Keefe 2001 Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment Am J Psychiatry 158 176 184 10.1176/appi.ajp.158.2.176 1:STN:280:DC%2BD3M7ktFKjsw%3D%3D 11156796 (Pubitemid 32116511)
25. RM Bilder RS Goldman J Volavka P Czobor M Hoptman B Sheitman JP Lindenmayer L Citrome J McEvoy M Kunz M Chakos TB Cooper TL Horowitz JA Lieberman 2002 Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder Am J Psychiatry 159 6 1018 1028 10.1176/appi.ajp.159.6.1018 12042192 (Pubitemid 34586949)
26. PJ Tyson KR Laws KA Flowers A Tyson AM Mortimer 2006 Cognitive function and social abilities in patients with schizophrenia: relationship with atypical antipsychotics Psychiatry Clin Neurosci 60 473 479 10.1111/j.1440-1819.2006. 01534.x 1:CAS:528:DC%2BD28XpslWitLs%3D 16884450 (Pubitemid 44060805)
27. JG Ramaekers JW Louwerens ND Muntjewerff H Milius A de Bie P Rosenzweig A Patat JF O'Hanlon 1999 Psychomotor, cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic J Clin Psychopharmacol 19 209 221 10.1097/00004714-199906000-00003 1:CAS:528:DyaK1MXjs1ant70%3D 10350027 (Pubitemid 29233015)
28. P Rosenzweig M Canal A Patat L Bergougnan L Zieleniuk G Bianchetti 2002 A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers Hum Psychopharmacol 17 1 13 10.1002/hup.320 1:CAS:528:DC%2BD38XhvFGlu78%3D 12404702 (Pubitemid 34130349)
29. MJ Mattila A Patat T Seppaelea H Kalska M-L Jalava J Vanakoski C Lavanant 1996 Single oral doses of amisulpride do not enhance the effects of alcohol on the performance and memory of healthy subjects Eur J Clin Pharmacol 51 161 166 10.1007/s002280050178 1:CAS:528:DyaK28XntVGgtLg%3D 8911882 (Pubitemid 26342773)
30. DI Velligan J Newcomer J Pultz J Csernansky AL Hoff R Mahurin AL Miller 2002 Does cognitive function improve with quetiapine in comparison to haloperidol? Schizophr Res 53 239 248 10.1016/S0920-9964(01)00268-7 11738537 (Pubitemid 34008588)
31. KW Sax SM Strakowski PE Keck Jr 1998 Attentional improvement following quetiapine fumarate treatment in schizophrenia Schizophr Res 33 151 155 10.1016/S0920-9964(98)00067-X 1:STN:280:DyaK1M%2Fgs1egtA%3D%3D 9789907 (Pubitemid 28446539)
32. BB Kivircik Akdede K Alptekin A Kitis H Arkar Y Akvardar 2005 Effects of quetiapine on cognitive functions in schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 29 233 238 10.1016/j.pnpbp.2004.11.005 1:CAS:528: DC%2BD2MXptlCqtw%3D%3D 15694229 (Pubitemid 40202908)
33. LC Kopala KP Good H Milliken C Buiteman H Woodley Q Rui D Whitehorn L Love R Balshaw R Kiss WG Honer 2006 Treatment of a first episode of psychotic illness with quetiapine: an analysis of 2 year outcomes Schizophr Res 81 29 39 10.1016/j.schres.2005.09.009 16263246 (Pubitemid 41817204)
34. M Riedel I Spellman M Strassnig A Douhet S Dehning M Opgen-Rhein R Valdevit RR Engel N Kleindienst N Müller HJ Möller 2007 Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms Eur Arch Psychiatry Clin Neurosci 257 360 370 10.1007/s00406-007-0739-x 17629731 (Pubitemid 47476724)